menu
    • menu

    Company profile for Microbiotica

    NEW Drugs in Dev: 2
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    The microbiome represents a paradigm shift that affects every aspect of biomedicine: our gut bacteria control health, disease and drug response throughout the body, and can themselves be a novel type of medicine. The microbiome therefore has the potential to be a major new therapeutic modality. Microbiotica was founded by Dr Trevor Lawley, Prof Gordon Dougan FRS and Dr Mike Romanos in December 2016 to exploit fundamental adva...
    The microbiome represents a paradigm shift that affects every aspect of biomedicine: our gut bacteria control health, disease and drug response throughout the body, and can themselves be a novel type of medicine. The microbiome therefore has the potential to be a major new therapeutic modality. Microbiotica was founded by Dr Trevor Lawley, Prof Gordon Dougan FRS and Dr Mike Romanos in December 2016 to exploit fundamental advances made at the Sanger Institute to address barriers to the translation of the microbiome. A central premise has been that a more rigorous and comprehensive analysis.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Microbioticaunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Biodata Innovation Centre Wellcome Genome Campus Cambridge CB10 1DR
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://microbiotica.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/microbiotica-limited/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Natural Product Expo West

    Natural Product Expo West

    Not Confirmed

    envelop Contact Supplier

    Natural Product Expo West

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Microbiotica's MB310 Succeeds in Phase 1b Ulcerative Colitis
    Microbiotica's MB310 Succeeds in Phase 1b Ulcerative Colitis

    11 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-11/microbiotica-announces-impressive-results-in-its-phase-1b-trial-of-mb310-in-ulcerative-colitis

    PHARMIWEB
    11 Feb 2026
    Share Share
    Microbiotica Completes Global Phase 1b of MB097 Trial Enrollment
    Microbiotica Completes Global Phase 1b of MB097 Trial Enrollment

    24 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-24/microbiotica-announces-completion-of-recruitment-in-its-international-phase-1b-trial-melody-1-of-mb097-a-precision-microbiome-co-therapy-in-advance

    PHARMAWEB
    24 Sep 2025
    Share Share
    Microbiotica Completes Recruitment for Intl Ph 1b Trial of MB097
    Microbiotica Completes Recruitment for Intl Ph 1b Trial of MB097

    19 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-19/microbiotica-announces-completion-of-recruitment-in-its-international-phase-1b-trial-melody-1-of-mb097-a-precision-microbiome-co-therapy-in-advance

    PHARMAWEB
    19 Sep 2025
    Share Share
    Microbiotica Shares MB097 Data in Advanced Melanoma
    Microbiotica Shares MB097 Data in Advanced Melanoma

    26 Feb 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-02-26/microbiotica-presented-new-data-on-the-mechanism-of-action-of-mb097-a-clinical-stage-drug-candidate-being-developed-as-a-co-therapy-in-combination-with-keytruda-pembrolizumab-in-patients-with-advanced-melanoma

    PHARMAWEB
    26 Feb 2025
    Share Share
    Microbiotica Announces Transition of Leadership
    Microbiotica Announces Transition of Leadership

    29 Nov 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221129005146/en

    BUSINESSWIRE
    29 Nov 2022
    Share Share
    Microbiotica Raises £50m to Advance Pipeline of Microbiome-based Therapeutics
    Microbiotica Raises £50m to Advance Pipeline of Microbiome-based Therapeutics

    07 Mar 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220307005475/en

    BUSINESSWIRE
    07 Mar 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search